NDC 68001-265 – Etoposide
Etoposide 20 mg/mL · Injection · Intravenous
Product NDC68001-265
Product details
- Brand name
- Etoposide
- Generic name
- Etoposide
- Labeler
- BluePoint Laboratories
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- ANDA · ANDA074513
- Marketed since
- November 14, 2013
- Listing expires
- December 31, 2026
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Etoposide 20 mg/mL
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 68001-265-25 | 1 VIAL, MULTI-DOSE in 1 BOX (68001-265-25) / 5 mL in 1 VIAL, MULTI-DOSE (68001-265-22) | Nov 14, 2013 |
| 68001-265-26 | 1 VIAL, MULTI-DOSE in 1 BOX (68001-265-26) / 25 mL in 1 VIAL, MULTI-DOSE (68001-265-23) | Nov 14, 2013 |
| 68001-265-27 | 1 VIAL, MULTI-DOSE in 1 BOX (68001-265-27) / 50 mL in 1 VIAL, MULTI-DOSE (68001-265-24) | Nov 14, 2013 |
Other Etoposide products
- 16729-114 Etoposide 20 mg/mL · Injection · Accord Healthcare Inc.
- 0143-9376 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9510 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9511 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9512 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 68001-681 Etoposide 20 mg/mL · Injection, Solution, Concentrate · BluePoint Laboratories
- 68001-682 Etoposide 20 mg/mL · Injection, Solution, Concentrate · BluePoint Laboratories
- 68001-683 Etoposide 20 mg/mL · Injection, Solution, Concentrate · BluePoint Laboratories
- 63323-104 Etoposide 20 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 71288-175 Etoposide 20 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.
- 71288-176 Etoposide 20 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.
- 71288-177 Etoposide 20 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.